Healx

About:

Healx is a rare disease biotechnology company that uses generative AI for drug discovery.

Website: https://healx.ai

Twitter/X: healx

Top Investors: Intel Capital, Global Brain Corporation, Amadeus Capital Partners, VU Venture Partners, Balderton Capital

Description:

Healx is a rare disease biotechnology company that uses generative AI for drug discovery. Healx utilizes advanced artificial intelligence (AI) and machine learning technologies to identify potential drug candidates and repurpose existing drugs for new therapeutic applications. By focusing on drug repurposing, Healx aims to find new uses for existing medications, leveraging their known safety profiles and reducing the risk and cost associated with developing new drugs from scratch.

Total Funding Amount:

$115M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2014-01-01

Contact Email:

info(AT)healx.io

Founders:

Andreas Bender, David Brown, David Cavalla, Tim Guilliams

Number of Employees:

101-250

Last Funding Date:

2024-08-01

IPO Status:

Private

© 2024 MyAiNote.com